UK’s Prime Minister Keir Starmer has set his sights on making the UK a global superpower in the AI space. He wants the industry to grow and create rivals to OpenAI in a move calculated to significantly grow domestic computing power … Continue reading →

Calidi Biotherapeutics (NYSE American: CLDI), a clinical-stage biotechnology company specializing in targeted antitumor virotherapies, announced its abstract, “Development of a Systemic Enveloped Virotherapy for Targeting All Metastatic Sites,” has been accepted for presentation at the American Association for Cancer Research … Continue reading →

D-Wave Quantum Inc. (NYSE: QBTS) (“D-Wave”), a leader in quantum computing systems, software, and services, announced that CEO Dr. Alan Baratz appeared on CNBC’s “The Exchange” on January 8th to address recent comments by NVIDIA CEO Jensen Huang regarding quantum … Continue reading →

McEwen Mining (NYSE: MUX) (TSX: MUX) was highlighted in a recent article that discussed favorable positioning of the United States in the AI sector. “Sam Altman, the CEO of OpenAI, has voiced his confidence in President-elect Donald Trump supporting the AI … Continue reading →

Calidi Biotherapeutics (NYSE American: CLDI), a clinical-stage biotechnology company focused on targeted immunotherapies, has priced its public offering of 5,000,000 shares of common stock at $0.85 per share, with gross proceeds expected to total approximately $4.25 million before fees and … Continue reading →

South Dakota ranks No. 1 in the nation for statewide public safety efforts and related infrastructure, according to a review published last fall by health and safety experts at CPR educators ProTrainings (https://ibn.fm/oWTk1). The study’s findings were based on the … Continue reading →

D-Wave Quantum (NYSE: QBTS) (“D-Wave”), a leader in quantum computing systems, software and services, and the first commercial provider of quantum computers, announced that it has completed its second SOC 2 Type 2 audit, a reflection of its ability to provide … Continue reading →

Clene (NASDAQ: CLNN) and its wholly owned subsidiary, Clene Nanomedicine Inc., is a late clinical-stage biopharmaceutical company focused on improving mitochondrial health and protecting neuronal function to treat neurodegenerative diseases, including amyotrophic lateral sclerosis (“ALS”) and multiple sclerosis (“MS”). The company … Continue reading →

The government in Israel has set up a new office based at the Defense Ministry. This office will superintend over the development of technology focused on AI and autonomy. Dubbed the AI & Autonomy Administration, this team will operate under the auspices … Continue reading →

SolarBank (NASDAQ: SUUN) (CSE: SUNN) is a premier developer and owner of renewable and clean energy projects, specializing in distributed and community solar initiatives throughout Canada and the United States. The company is committed to advancing the transition to sustainable energy … Continue reading →

Annovis Bio (NYSE: ANVS), a late-stage clinical drug platform company pioneering transformative therapies for neurodegenerative diseases such as Alzheimer’s disease (“AD”) and Parkinson’s disease (“PD”), today announced that the FDA has accepted an updated protocol for the pivotal Phase 3 … Continue reading →

D-Wave Quantum (NYSE: QBTS) (“D-Wave”), a leader in quantum computing systems, software and services, and the first commercial provider of quantum computers, announced recently that its CEO Dr. Alan Baratz was interviewed on Fox Business’ Making Money with Charles Payne, … Continue reading →